Observational report examines COVID-19 vaccine provider access and coverage in U.S. children
How does vaccine access affect COVID-19 shots for young children?
An observational report examined COVID-19 vaccination coverage and provider access among U.S. children aged 5-11 years. No specific results,…
A new report maps how easy it is for U.S. families with children aged 5 to 11 to find COVID-19 vaccine shots.
ACIP issues interim recommendation for Janssen COVID-19 vaccine in the United States.
What does the new recommendation for the Johnson & Johnson COVID vaccine mean?
The Advisory Committee on Immunization Practices (ACIP) has issued an interim recommendation for the use of the Janssen COVID-19 vaccine. Th…
A U.S. health committee gave an interim green light for the Johnson & Johnson COVID vaccine as a prevention option after reviewing available…
ACIP issues interim recommendations for bivalent COVID-19 booster vaccines
Health officials issue interim recommendations for updated COVID-19 booster vaccines
The Advisory Committee on Immunization Practices (ACIP) has issued interim recommendations for the use of bivalent COVID-19 booster vaccines…
U.S. health experts issued interim guidance on who should receive updated bivalent COVID-19 booster vaccines based on current evidence.
MIS-C Reported in US Children and Adolescents Following COVID-19 Onset
U.S. report describes MIS-C inflammatory syndrome in children after COVID-19
An observational report from the United States describes clinical signs and symptoms of multisystem inflammatory syndrome in children (MIS-C…
A U.S. health report describes cases of a serious inflammatory condition in children that appeared after they had COVID-19.
Observational data show fewer COVID-19 hospitalizations and symptoms in U.S. children versus adults
Early U.S. data suggests children with COVID-19 may have milder symptoms than adults
A preliminary observational description of pediatric COVID-19 cases in the U.S. suggests relatively few children are hospitalized and fewer …
Early U.S. data suggests children with COVID-19 may have milder symptoms than adults, with fewer hospitalizations and less fever or cough re…
Observational study finds 16% COVID-19 vaccination coverage among pregnant people in U.S.
How many pregnant people got COVID shots? Early data shows gaps.
An observational study of pregnant people in eight U.S. healthcare organizations found COVID-19 vaccination coverage was 16% as of May 2021,…
By May 2021, only 16% of pregnant people in the U.S. had received a COVID-19 vaccine, with coverage dropping to just 6% for Black people and…
Survey explores clinician COVID-19 vaccination practices for women of reproductive age
How do doctors talk to women about COVID vaccines? A new survey asks.
A survey of U.S. clinicians who offer COVID-19 vaccines to women of reproductive age, including pregnant patients, was conducted. No specifi…
A new survey asks U.S. doctors how they talk to pregnant women about COVID-19 vaccines and what guidance they offer.
Report examines influenza, Tdap, and COVID-19 vaccination coverage and hesitancy in pregnant women
How many pregnant women are getting their recommended vaccines?
An observational report from the United States describes influenza, Tdap, and COVID-19 vaccination coverage and hesitancy among pregnant wom…
A new report examines how many pregnant people are getting flu, Tdap, and COVID-19 vaccines and explores reasons behind any hesitation.
Interim Recommendation Issued for Moderna COVID-19 Vaccine in Adults
Health officials issue interim recommendation for Moderna COVID-19 vaccine in adults
An interim recommendation for the use of the Moderna COVID-19 vaccine in persons aged 18 years and older in the United States has been issue…
Health officials issued an interim recommendation for adults to receive the Moderna COVID-19 vaccine in the United States.
ACIP issues interim guidance for initial COVID-19 vaccine allocation in the United States
Health officials issue interim guidance for initial COVID-19 vaccine allocation
The Advisory Committee on Immunization Practices (ACIP) has issued interim guidance for the initial allocation of COVID-19 vaccine in the Un…
Health officials released interim guidance to help states plan the fair distribution of the first limited COVID-19 vaccine supplies to healt…
ACIP Issues Interim Recommendation for Pfizer-BioNTech COVID-19 Vaccine in Adults
What did health officials recommend for COVID-19 vaccination in late 2020?
The Advisory Committee on Immunization Practices issued an interim recommendation for use of the Pfizer-BioNTech COVID-19 vaccine in persons…
On December 12, 2020, medical experts gave the green light for Pfizer-BioNTech COVID-19 vaccines for people aged 16 and older.
ACIP Issues Standard Recommendation for Pfizer-BioNTech COVID-19 Vaccine in Adults
CDC panel recommends Pfizer COVID-19 vaccine for people 16 and older
The ACIP has issued a standard recommendation for use of the Pfizer-BioNTech COVID-19 vaccine in persons aged ≥16 years in the United States…
An expert panel now recommends the Pfizer COVID-19 vaccine for everyone aged 16 and older in the United States.